1-8 of 8
Sharon Wilczynski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy

Nicola R. Hardwick, Paul Frankel, Christopher Ruel, Julie Kilpatrick, Weimin Tsai, Ferdynand Kos, Teodora Kaltcheva, Lucille Leong, Robert Morgan, Vincent Chung, Raechelle Tinsley, Melissa Eng, Sharon Wilczynski, Joshua D.I. Ellenhorn, Don J. Diamond, Mihaela Cristea
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (6): 1315–1325.
https://doi.org/10.1158/1078-0432.CCR-17-2709
Published: 14 March 2018
View article titled, p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy
Open the PDF for p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine Chemotherapy in another window
Includes: Supplementary data
Journal Articles

Abstract B38: The role of TWIST1 in chemoresistance and metastasis in ovarian cancer – potential therapeutic applications

Cai Roberts, Ernest S. Han, Gina Lowe, James Finlay, Sharon Wilczynski, Lucy Ghoda, Carlotta Glackin, Thanh H. Dellinger
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (19_Supplement): B38.
https://doi.org/10.1158/1078-0432.OVCA13-B38
Published: 13 May 2014
View article titled, Abstract B38: The role of TWIST1 in chemoresistance and metastasis in ovarian cancer – potential therapeutic applications
Journal Articles

Pilot Trial Evaluating an 123I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer

Jeffrey Y. C. Wong, David Z. Chu, Lawrence E. Williams, Dave M. Yamauchi, David N. Ikle, Cheuk S. Kwok, An Liu, Sharon Wilczynski, David Colcher, Paul J. Yazaki, John E. Shively, Anna M. Wu, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (15): 5014–5021.
https://doi.org/10.1158/1078-0432.CCR-03-0576
Published: 05 August 2004
View article titled, Pilot Trial Evaluating an <sup>123</sup>I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer
Open the PDF for Pilot Trial Evaluating an <sup>123</sup>I-Labeled 80-Kilodalton Engineered Anticarcinoembryonic Antigen Antibody Fragment (cT84.66 Minibody) in Patients with Colorectal Cancer in another window
Journal Articles

A Phase I Trial of 90Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer

Jeffrey Y. C. Wong, Stephen Shibata, Lawrence E. Williams, Cheuk S. Kwok, An Liu, David Z. Chu, Dave M. Yamauchi, Sharon Wilczynski, David N. Ikle, Anna M. Wu, Paul J. Yazaki, John E. Shively, James H. Doroshow, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5842–5852.
Published: 15 December 2003
View article titled, A Phase I Trial of <sup>90</sup>Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer
Open the PDF for A Phase I Trial of <sup>90</sup>Y-Anti-Carcinoembryonic Antigen Chimeric T84.66 Radioimmunotherapy with 5-Fluorouracil in Patients with Metastatic Colorectal Cancer in another window
Journal Articles

Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients

Goli Samimi, Nissi M. Varki, Sharon Wilczynski, Roohangiz Safaei, David S. Alberts, Stephen B. Howell
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (16): 5853–5859.
Published: 15 December 2003
View article titled, Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients
Open the PDF for Increase in Expression of the Copper Transporter ATP7A during Platinum Drug-Based Treatment Is Associated with Poor Survival in Ovarian Cancer Patients in another window
Journal Articles

A Phase I Radioimmunotherapy Trial Evaluating 90Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies

Jeffrey Y. C. Wong, David Z. Chu, Dave M. Yamauchi, Lawrence E. Williams, An Liu, Sharon Wilczynski, Anna M. Wu, John E. Shively, James H. Doroshow, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (10): 3855–3863.
Published: 01 October 2000
View article titled, A Phase I Radioimmunotherapy Trial Evaluating <sup>90</sup>Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies
Open the PDF for A Phase I Radioimmunotherapy Trial Evaluating <sup>90</sup>Yttrium-labeled Anti-Carcinoembryonic Antigen (CEA) Chimeric T84.66 in Patients with Metastatic CEA-producing Malignancies in another window
Journal Articles

A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive

Laila Muderspach, Sharon Wilczynski, Linda Roman, Liz Bade, Juan Felix, L. A. Small, W. Martin Kast, Grace Fascio, Verna Marty, Jeffrey Weber
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (9): 3406–3416.
Published: 01 September 2000
View article titled, A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive
Open the PDF for A Phase I Trial of a Human Papillomavirus (HPV) Peptide Vaccine for Women with High-Grade Cervical and Vulvar Intraepithelial Neoplasia Who Are HPV 16 Positive in another window
Journal Articles

Initial Clinical Experience Evaluating Yttrium-90-Chimeric T84.66 Anticarcinoembryonic Antigen Antibody and Autologous Hematopoietic Stem Cell Support in Patients with Carcinoembryonic Antigen-producing Metastatic Breast Cancer

Jeffrey Y. C. Wong, George Somlo, Tamara Odom-Maryon, Lawrence E. Williams, An Liu, Dave Yamauchi, Anna M. Wu, Paul Yazaki, Sharon Wilczynski, John E. Shively, Stephen Forman, James H. Doroshow, Andrew A. Raubitschek
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (10): 3224s–3231s.
Published: 01 October 1999
View article titled, Initial Clinical Experience Evaluating Yttrium-90-Chimeric T84.66 Anticarcinoembryonic Antigen Antibody and Autologous Hematopoietic Stem Cell Support in Patients with Carcinoembryonic Antigen-producing Metastatic Breast Cancer
Open the PDF for Initial Clinical Experience Evaluating Yttrium-90-Chimeric T84.66 Anticarcinoembryonic Antigen Antibody and Autologous Hematopoietic Stem Cell Support in Patients with Carcinoembryonic Antigen-producing Metastatic Breast Cancer in another window